Genmab A GMAB
NASDAQ GMAB
$34.74 +0.21 (+0.61%)
At close: Sep 18, 2026 · 4:00 PM EDT

Genmab A (GMAB) Change in Intangibles (2023 - 2025)

Genmab A's (GMAB) quarterly Change in Intangibles came in at -$18.0 million in Q3 2025, down 800.0% on a YoY basis from $2.6 million in Q3 2024, and little changed quarter-over-quarter from -$18.0 million in Q2 2025.

Analysis

Genmab A (GMAB) Change in Intangibles (2023 - 2025) Analysis & Trends

Genmab A (GMAB) has reported Change in Intangibles for 3 consecutive years, with -$18.0 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Change in Intangibles fell 800.0% year-over-year to -$18.0 million; the trailing twelve-month figure through Sep 2025 stood at -$71.0 million (down 2266.67% YoY), and the FY2025 full-year result was -$18.0 million, down 5.88% from the prior year.
  • Change in Intangibles steadied at -$18.0 million in Q3 2025 per GMAB's latest filing, from -$18.0 million in the prior quarter.
  • Across five years, Change in Intangibles topped out at -$1.0 million in Q4 2023 and bottomed at -$18.0 million in Q1 2025.
  • Historically, Change in Intangibles has averaged -$12.3 million across 3 years, with a median of -$17.5 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Change in Intangibles sank 1600.0% in 2024, then sank 800.0% in 2025.
  • Over 3 years, Change in Intangibles stood at -$1.0 million in 2023, then tumbled by 1600.0% to -$17.0 million in 2024, then declined by 5.88% to -$18.0 million in 2025.
  • According to Business Quant data, Change in Intangibles over the past three periods registered -$18.0 million, -$18.0 million, and -$18.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Intangibles (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn -
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn -
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn -
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn -
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn -
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn -
10 Genmab A 2.23 Bn 728.64 Mn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -18.00 Mn
Jun 30, 2025 -18.00 Mn
Mar 31, 2025 -18.00 Mn
Dec 31, 2024 -17.00 Mn
Sep 30, 2024 -2.00 Mn
Dec 31, 2023 -1.00 Mn